1918 related articles for article (PubMed ID: 33513419)
21. Integrated network pharmacology analysis and in vitro validation revealed the underlying mechanism of Xiyanping injection in treating coronavirus disease 2019.
Li J; Guo S; Tan Y; Zhang J; Wu Z; Stalin A; Zhang F; Huang Z; Wu C; Liu X; Huang J; Wu J
Medicine (Baltimore); 2023 Aug; 102(34):e34866. PubMed ID: 37653800
[TBL] [Abstract][Full Text] [Related]
22. Identification of FDA approved drugs against SARS-CoV-2 RNA dependent RNA polymerase (RdRp) and 3-chymotrypsin-like protease (3CLpro), drug repurposing approach.
Molavi Z; Razi S; Mirmotalebisohi SA; Adibi A; Sameni M; Karami F; Niazi V; Niknam Z; Aliashrafi M; Taheri M; Ghafouri-Fard S; Jeibouei S; Mahdian S; Zali H; Ranjbar MM; Yazdani M
Biomed Pharmacother; 2021 Jun; 138():111544. PubMed ID: 34311539
[TBL] [Abstract][Full Text] [Related]
23. Identifying potential treatments of COVID-19 from Traditional Chinese Medicine (TCM) by using a data-driven approach.
Ren X; Shao XX; Li XX; Jia XH; Song T; Zhou WY; Wang P; Li Y; Wang XL; Cui QH; Qiu PJ; Zhao YG; Li XB; Zhang FC; Li ZY; Zhong Y; Wang ZG; Fu XJ
J Ethnopharmacol; 2020 Aug; 258():112932. PubMed ID: 32376368
[TBL] [Abstract][Full Text] [Related]
24. Investigation of the Active Ingredients and Mechanism of Hudi Enteric-Coated Capsules in DSS-Induced Ulcerative Colitis Mice Based on Network Pharmacology and Experimental Verification.
Ding P; Liu J; Li Q; Lu Q; Li J; Shi R; Shi L; Mao T; Ge D; Niu H; Peng G; Wang Z
Drug Des Devel Ther; 2021; 15():4259-4273. PubMed ID: 34675488
[TBL] [Abstract][Full Text] [Related]
25. Network pharmacology analysis of the therapeutic mechanisms of the traditional Chinese herbal formula Lian Hua Qing Wen in Corona virus disease 2019 (COVID-19), gives fundamental support to the clinical use of LHQW.
Zheng S; Baak JP; Li S; Xiao W; Ren H; Yang H; Gan Y; Wen C
Phytomedicine; 2020 Dec; 79():153336. PubMed ID: 32949888
[TBL] [Abstract][Full Text] [Related]
26. Network pharmacology, molecular docking, and dynamics analyses to predict the antiviral activity of ginger constituents against coronavirus infection.
Samy A; Hassan A; Hegazi NM; Farid M; Elshafei M
Sci Rep; 2024 May; 14(1):12059. PubMed ID: 38802394
[TBL] [Abstract][Full Text] [Related]
27. Bioactive Components of
Yuan H; Liu L; Zhou J; Zhang T; Daily JW; Park S
J Med Food; 2022 Apr; 25(4):355-366. PubMed ID: 35438554
[TBL] [Abstract][Full Text] [Related]
28. Potential Targets and Mechanisms of Bitter Almond-Licorice for COVID-19 Treatment Based on Network Pharmacology and Molecular Docking.
Hong Q; Shang X; Wu Y; Nie Z; He B
Curr Pharm Des; 2023; 29(33):2655-2667. PubMed ID: 38018195
[TBL] [Abstract][Full Text] [Related]
29. Isolation and identification of the components in Cybister chinensis Motschulsky against inflammation and their mechanisms of action based on network pharmacology and molecular docking.
Che YH; Xu ZR; Ni LL; Dong XX; Yang ZZ; Yang ZB
J Ethnopharmacol; 2022 Mar; 285():114851. PubMed ID: 34808299
[TBL] [Abstract][Full Text] [Related]
30. Mechanism of Sanhua Decoction in the Treatment of Ischemic Stroke Based on Network Pharmacology Methods and Experimental Verification.
YingHuang ; Gao SS; Gong ZH; Li WJ; Xiao-junGou ; Sun JJ; Sun MJ
Biomed Res Int; 2022; 2022():7759402. PubMed ID: 35097126
[TBL] [Abstract][Full Text] [Related]
31. In Silico Screening of Potential Chinese Herbal Medicine Against COVID-19 by Targeting SARS-CoV-2 3CLpro and Angiotensin Converting Enzyme II Using Molecular Docking.
Gao LQ; Xu J; Chen SD
Chin J Integr Med; 2020 Jul; 26(7):527-532. PubMed ID: 32632717
[TBL] [Abstract][Full Text] [Related]
32. Active components in Ephedra sinica stapf disrupt the interaction between ACE2 and SARS-CoV-2 RBD: Potent COVID-19 therapeutic agents.
Mei J; Zhou Y; Yang X; Zhang F; Liu X; Yu B
J Ethnopharmacol; 2021 Oct; 278():114303. PubMed ID: 34102269
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic Mechanism of Xiaoqinglong Decoction against COVID-19 Based on Network Pharmacology and Molecular Docking Technology.
Li HL; Zhou JP; Deng JM
Comb Chem High Throughput Screen; 2022; 25(13):2264-2277. PubMed ID: 35227178
[TBL] [Abstract][Full Text] [Related]
34. Protection against COVID-19 injury by qingfei paidu decoction via anti-viral, anti-inflammatory activity and metabolic programming.
Chen J; Wang YK; Gao Y; Hu LS; Yang JW; Wang JR; Sun WJ; Liang ZQ; Cao YM; Cao YB
Biomed Pharmacother; 2020 Sep; 129():110281. PubMed ID: 32554251
[TBL] [Abstract][Full Text] [Related]
35. Liujunzi Decoction ameliorated cisplatin-induced anorexia by inhibiting the JAK-STAT signaling pathway and coordinating anorexigenic and orexigenic neuropeptides in rats.
Dai Y; Chen S; Li Y; Zhang G; Bi P; Nie K
J Ethnopharmacol; 2022 Mar; 285():114840. PubMed ID: 34800646
[TBL] [Abstract][Full Text] [Related]
36. Mechanism underlying efficacy of Shugan Sanjie decoction on plasma cell mastitis, based on network pharmacology and experimental verification.
Nan Q; Qinnan W; Chaoqun MA; Dexuan C; Haidong C; Yaoyao LU
J Tradit Chin Med; 2022 Jun; 42(3):400-407. PubMed ID: 35610009
[TBL] [Abstract][Full Text] [Related]
37. [Rapid establishment of traditional Chinese medicine prevention and treatment of 2019-nCoV based on clinical experience and molecular docking].
Niu M; Wang RL; Wang ZX; Zhang P; Bai ZF; Jing J; Guo YM; Zhao X; Zhan XY; Zhang ZT; Song XA; Qin EQ; Wang JB; Xiao XH
Zhongguo Zhong Yao Za Zhi; 2020 Mar; 45(6):1213-1218. PubMed ID: 32281327
[TBL] [Abstract][Full Text] [Related]
38. Investigating the mechanism of ShuFeng JieDu capsule for the treatment of novel Coronavirus pneumonia (COVID-19) based on network pharmacology.
Chen X; Yin YH; Zhang MY; Liu JY; Li R; Qu YQ
Int J Med Sci; 2020; 17(16):2511-2530. PubMed ID: 33029094
[TBL] [Abstract][Full Text] [Related]
39. Utilizing integrating network pharmacological approaches to investigate the potential mechanism of Ma Xing Shi Gan Decoction in treating COVID-19.
Wang YX; Ma JR; Wang SQ; Zeng YQ; Zhou CY; Ru YH; Zhang L; Lu ZG; Wu MH; Li H
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3360-3384. PubMed ID: 32271454
[TBL] [Abstract][Full Text] [Related]
40. Screening and evaluation of anti-SARS-CoV-2 components from Ephedra sinica by ACE2/CMC-HPLC-IT-TOF-MS approach.
Lv Y; Wang S; Liang P; Wang Y; Zhang X; Jia Q; Fu J; Han S; He L
Anal Bioanal Chem; 2021 May; 413(11):2995-3004. PubMed ID: 33608752
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
